294 related articles for article (PubMed ID: 19398463)
1. Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial.
Agthe AG; Kim GR; Mathias KB; Hendrix CW; Chavez-Valdez R; Jansson L; Lewis TR; Yaster M; Gauda EB
Pediatrics; 2009 May; 123(5):e849-56. PubMed ID: 19398463
[TBL] [Abstract][Full Text] [Related]
2. Diluted tincture of opium (DTO) and phenobarbital versus DTO alone for neonatal opiate withdrawal in term infants.
Coyle MG; Ferguson A; Lagasse L; Oh W; Lester B
J Pediatr; 2002 May; 140(5):561-4. PubMed ID: 12032522
[TBL] [Abstract][Full Text] [Related]
3. Treatment of neonatal withdrawal with clonidine after long-term, high-dose maternal use of tramadol.
O'Mara K; Gal P; Davanzo C
Ann Pharmacother; 2010; 44(7-8):1342-4. PubMed ID: 20587741
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Safety and Efficacy of Methadone vs Morphine for Treatment of Neonatal Abstinence Syndrome: A Randomized Clinical Trial.
Davis JM; Shenberger J; Terrin N; Breeze JL; Hudak M; Wachman EM; Marro P; Oliveira EL; Harvey-Wilkes K; Czynski A; Engelhardt B; D'Apolito K; Bogen D; Lester B
JAMA Pediatr; 2018 Aug; 172(8):741-748. PubMed ID: 29913015
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of clonidine versus phenobarbital in reducing neonatal morphine sulfate therapy days for neonatal abstinence syndrome. A prospective randomized clinical trial.
Surran B; Visintainer P; Chamberlain S; Kopcza K; Shah B; Singh R
J Perinatol; 2013 Dec; 33(12):954-9. PubMed ID: 23949834
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic approaches for neonatal abstinence syndrome: a systematic review of randomized clinical trials.
Ghazanfarpour M; Najafi MN; Roozbeh N; Mashhadi ME; Keramat-Roudi A; Mégarbane B; Tsatsakis A; Moghaddam MMM; Rezaee R
Daru; 2019 Jun; 27(1):423-431. PubMed ID: 31093953
[TBL] [Abstract][Full Text] [Related]
7. Neurobehavioral effects of treatment for opiate withdrawal.
Coyle MG; Ferguson A; Lagasse L; Liu J; Lester B
Arch Dis Child Fetal Neonatal Ed; 2005 Jan; 90(1):F73-4. PubMed ID: 15613582
[TBL] [Abstract][Full Text] [Related]
8. Use of clonidine in the prevention and management of neonatal abstinence syndrome.
Leikin JB; Mackendrick WP; Maloney GE; Rhee JW; Farrell E; Wahl M; Kelly K
Clin Toxicol (Phila); 2009 Jul; 47(6):551-5. PubMed ID: 19566381
[TBL] [Abstract][Full Text] [Related]
9. Treatment of neonatal abstinence syndrome with clonidine and chloral hydrate.
Esmaeili A; Keinhorst AK; Schuster T; Beske F; Schlösser R; Bastanier C
Acta Paediatr; 2010 Feb; 99(2):209-14. PubMed ID: 19839963
[TBL] [Abstract][Full Text] [Related]
10. Emerging therapies for the treatment of neonatal abstinence syndrome.
Frazier LM; Bobby LE; Gawronski KM
J Matern Fetal Neonatal Med; 2022 Mar; 35(5):987-995. PubMed ID: 32146833
[TBL] [Abstract][Full Text] [Related]
11. Clonidine versus phenobarbital as adjunctive therapy for neonatal abstinence syndrome.
Brusseau C; Burnette T; Heidel RE
J Perinatol; 2020 Jul; 40(7):1050-1055. PubMed ID: 32424335
[TBL] [Abstract][Full Text] [Related]
12. Phenobarbital and Clonidine as Secondary Medications for Neonatal Opioid Withdrawal Syndrome.
Merhar SL; Ounpraseuth S; Devlin LA; Poindexter BB; Young LW; Berkey SD; Crowley M; Czynski AJ; Kiefer AS; Whalen BL; Das A; Fuller JF; Higgins RD; Thombre V; Lester BM; Smith PB; Newman S; Sánchez PJ; Smith MC; Simon AE;
Pediatrics; 2021 Mar; 147(3):. PubMed ID: 33632932
[TBL] [Abstract][Full Text] [Related]
13. Therapy of the neonatal abstinence syndrome with tincture of opium or morphine drops.
Langenfeld S; Birkenfeld L; Herkenrath P; Müller C; Hellmich M; Theisohn M
Drug Alcohol Depend; 2005 Jan; 77(1):31-6. PubMed ID: 15607839
[TBL] [Abstract][Full Text] [Related]
14. Comparison of outcomes between morphine and concomitant morphine and clonidine treatments for neonatal abstinence syndrome.
Gullickson C; Kuhle S; Campbell-Yeo M
Acta Paediatr; 2019 Feb; 108(2):271-274. PubMed ID: 29972601
[TBL] [Abstract][Full Text] [Related]
15. A retrospective study of length of hospital stay in infants treated for neonatal abstinence syndrome with methadone versus oral morphine preparations.
Lainwala S; Brown ER; Weinschenk NP; Blackwell MT; Hagadorn JI
Adv Neonatal Care; 2005 Oct; 5(5):265-72. PubMed ID: 16202968
[TBL] [Abstract][Full Text] [Related]
16. Does the addition of clonidine to opioid therapy improve outcomes in infants with Neonatal Abstinence Syndrome?
D'Abaco E
J Paediatr Child Health; 2021 Jan; 57(1):155-159. PubMed ID: 33493373
[TBL] [Abstract][Full Text] [Related]
17. A Cohort Comparison of Buprenorphine versus Methadone Treatment for Neonatal Abstinence Syndrome.
Hall ES; Isemann BT; Wexelblatt SL; Meinzen-Derr J; Wiles JR; Harvey S; Akinbi HT
J Pediatr; 2016 Mar; 170():39-44.e1. PubMed ID: 26703873
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological Treatments for Neonatal Abstinence Syndrome: A Systematic Review and Network Meta-analysis.
Disher T; Gullickson C; Singh B; Cameron C; Boulos L; Beaubien L; Campbell-Yeo M
JAMA Pediatr; 2019 Mar; 173(3):234-243. PubMed ID: 30667476
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of a clinical pathway with methadone treatment protocol for treatment of neonatal abstinence syndrome following in utero drug exposure to substances of abuse*.
Bhatt-Mehta V; Ng CM; Schumacher RE
Pediatr Crit Care Med; 2014 Feb; 15(2):162-9. PubMed ID: 24141658
[TBL] [Abstract][Full Text] [Related]
20. Sublingual buprenorphine for treatment of neonatal abstinence syndrome: a randomized trial.
Kraft WK; Gibson E; Dysart K; Damle VS; Larusso JL; Greenspan JS; Moody DE; Kaltenbach K; Ehrlich ME
Pediatrics; 2008 Sep; 122(3):e601-7. PubMed ID: 18694901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
